sevenfact
(Coagulation Factor VIIa Recombinant Human)Laboratoire Français du Fractionnement et des Biotechnologies Société Anonyme (LFB S.A.)
Usage: SEVENFACT (coagulation factor VIIa) is indicated for treating and controlling bleeding episodes in adults and adolescents (12 years and older) with hemophilia A or B who have inhibitors. It is not intended for patients with congenital Factor VII deficiency.